CRISPR Therapeutics Stock Forecast
CRISPR Therapeutics stock upgraded to Sell Candidate.
(Updated on Apr 26, 2024)
The CRISPR Therapeutics stock price gained 0.335% on the last trading day (Friday, 26th Apr 2024), rising from $53.73 to $53.91. During the last trading day the stock fluctuated 4.02% from a day low at $52.81 to a day high of $54.94. The price has fallen in 6 of the last 10 days and is down by -11.14% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 86 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $71.34 million.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $53.43 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -19.59% during the next 3 months and, with a 90% probability hold a price between $42.96 and $61.50 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CRSP Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 0.335%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The CRISPR Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $55.22 and $65.51. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for CRISPR Therapeutics stock
CRISPR Therapeutics finds support from accumulated volume at $53.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.12 between high and low, or 4.02%. For the last week, the stock has had daily average volatility of 4.22%.
CRISPR Therapeutics is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CRSP) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect CRISPR Therapeutics AG to open at $53.89, and during the day (based on 14 day Average True Range), to move between $51.15 and $56.67, which gives a possible trading interval of +/-$2.76 (+/-5.12%) up or down from last closing price. If CRISPR Therapeutics AG takes out the full calculated possible swing range there will be an estimated 10.25% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $53.73 (0.33%) than the resistance at $55.05 (2.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is CRISPR Therapeutics AG stock A Buy?
CRISPR Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -3.043 Sell Candidate Upgraded
Predicted Opening Price for CRISPR Therapeutics AG of Monday, April 29, 2024
Fair opening price April 29, 2024 | Current price |
---|---|
$53.89 ( 0.0439%) | $53.91 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CRSP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 56.01 | 3.89 % | |
R2 | 55.20 | 2.39 % | ||
R1 | 54.70 | 1.46 % | ||
Current price: | 53.91 | |||
Support | S1 | 53.08 | -1.55 % | |
S2 | 52.58 | -2.48 % | ||
S3 | 51.77 | -3.98 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 65.78 | 22.02 % | |
R2 | 61.74 | 14.52 % | ||
R1 | 55.05 | 2.11 % | ||
Current price | 53.91 | |||
Support | S1 | 53.73 | -0.334% | |
S2 | 0 | . | ||
S3 | 0 | . |
FAQ
Click here for our free guide on how to buy CRISPR Therapeutics Stock.